¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Lumbosacral plexus disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mesenteric plexus
    âÀÚ°£¸·½Å°æ¾ó±â, Àå°£¸·½Å°æÃÑ
  • nerve plexus
    ½Å°æ¾ó±â
  • nasopalatine plexus
    ÄÚÀÔõÀå½Å°æ¾ó±â
  • pampiniform plexus
    µ¢±¼Á¤¸Æ¾ó±â
  • plexus
    ¾ó±â
  • plexus anesthesia
    ½Å°æ¾ó±â¸¶Ãë, ½Å°æÃѸ¶Ãë
  • presacral plexus
    ¾ûÄ¡¾ÕÁ¤¸Æ¾ó±â
  • prevertebral plexus
    ôÃ߾սŰæ¾ó±â
  • pterygoid plexus
    ³¯°³±ÙÁ¤¸Æ¾ó±â
  • periarterial nerve plexus
    µ¿¸ÆÁÖÀ§½Å°æ¾ó±â
  • rectal venous plexus
    Á÷ÀåÁ¤¸Æ¾ó±â, °ðâÀÚÁ¤¸Æ¾ó±â
  • splenic plexus
    Áö¶ó½Å°æ¾ó±â, ºñÀå½Å°æÃÑ
  • submucosal plexus
    Á¡¸·¹Ø½Å°æ¾ó±â, Á¡¸·ÇϽŰæÃÑ
  • sacral plexus
    ¾ûÄ¡½Å°æ¾ó±â
  • submucous plexus
    Á¡¸·¹Ø½Å°æ¾ó±â, Á¡¸·ÇϽŰæÃÑ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nerve plexus
    ½Å°æ¾ó±â
  • plexus
    ¾ó±â
  • pampiniform plexus
    µ¢±¼Á¤¸Æ¾ó±â
  • periarterial nerve plexus
    µ¿¸ÆÁÖÀ§½Å°æ¾ó±â
  • prevertebral plexus
    ôÃ߾սŰæ¾ó±â
  • pterygoid plexus
    ³¯°³±ÙÁ¤¸Æ¾ó±â
  • rectal venous plexus
    °ðâÀÚÁ¤¸Æ¾ó±â
  • sacral plexus
    ¾ûÄ¡½Å°æ¾ó±â
  • splenic plexus
    Áö¶ó½Å°æ¾ó±â
  • submucosal plexus
    Á¡¸·¹Ø½Å°æ¾ó±â
  • submucous plexus
    Á¡¸·¹Ø½Å°æ¾ó±â
  • subserosal plexus
    À帷¹Ø½Å°æ¾ó±â
  • tympanic plexus
    °í½Ç½Å°æ¾ó±â
  • venous plexus
    Á¤¸Æ¾ó±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hepatic plexus
    °£½Å°æ¾ó±â
  • hepatic plexus <³ª> p. hepaticius
    °£½Å°æ¾ó±â, °£½Å°æÃÑ.
  • hepatic plexus <³ª> p. hepaticus
    °£½Å°æÃÑ.
  • iliac plexus
    ¾ûµ¢½Å°æ¾ó±â
  • inferior mesenteric plexus
    ¾Æ·¡Ã¢ÀÚ°£¸·½Å°æ¾ó±â
  • inferior rectal plexus
    ¾Æ·¡°ðâÀڽŰæ¾ó±â
  • pharyngeal plexus
    ÀενŰæ¾ó±â
  • pharyngeal plexus
    ÀεÎÁ¤¸Æ¾ó±â
  • plexus
    ¾ó±â, ÃÑ(õ¿).
  • plexus anesthesia
    (½Å°æ)ÃѸ¶Ãë(¹ý)(ãêÌèõ¿Ø«ö­Ûö).
  • plexus aorticus abdominalis ³ª
    »À´ëµ¿¸Æ½Å°æ¾ó±â, º¹´ëµ¿¸Æ½Å°æÃÑ(ÜÙÓÞÔÑØæ ãêÌèõ¿).
  • plexus aorticus thoracicus ³ª
    °¡½¿´ëµ¿¸Æ½Å°æ¾ó±â, Èä´ëµ¿¸Æ½Å°æÃÑ(ýØÓÞÔÑ ØæãêÌèõ¿).
  • plexus arteriae cerebri anterioris ³ª
    ¾Õ´ë³úµ¿¸Æ¾ó±â, Àü´ë³úµ¿¸ÆÃÑ(îñÓÞ ÒàÔÑØæõ¿).
  • plexus arteriae cerebri mediae ³ª
    Áß°£´ë³úµ¿¸Æ¾ó±â, Áß´ë³úµ¿¸ÆÃÑ(ñéÓÞÒà ÔÑØæõ¿).
  • plexus arteriae chorioideae ³ª
    ¸Æ¶ô¸·µ¿¸Æ¾ó±â, ¸Æ¶ô¸·µ¿¸ÆÃÑ(ØæÕ©Ø¯ÔÑØæõ¿ ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • larynx, congenital disorders of the
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • learning disorders
    ÇнÀÀå¾Ö(ùÊã§î¡äô)(º´)
  • mendelian disorders
    ¸àµ¨ À¯Àü¼º Áúȯ(¡­ë¶îîàõ òðü´)
  • monoarticular disorders
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • movement disorders
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • neuroleptic-induced disorders
  • nutritional disorders
    ¿µ¾çÀÌ»ó<Àå¾Ö>.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Posterior internal vertebral venous plexus
    µÚ¼ÓôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Èij»Ãß°ñÁ¤¸ÆÃÑ
  • Suboccipital venous plexus
    µÚÅë¼ö¹ØÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ÈĵÎÇÏÁ¤¸ÆÃÑ
  • Lymphatic plexus
    ¸²ÇÁ°ü¾ó±â
    [¿¾ ¿ë¾î] ÀӯİüÃÑ
  • Lymphatic plexus
    ¸²ÇÁ¾ó±â
    [¿¾ ¿ë¾î] ÀÓÆÄÃÑ
  • Subgemmal nerve plexus
    ¸ÀºÀ¿À¸®¹Ø½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¹Ì·ÚÇϽŰæÃÑ
  • Vascular plexus
    ¸Æ°ü¾ó±â
    [¿¾ ¿ë¾î] ¸Æ°üÃÑ
  • Perivascular nerve plexus
    ¸Æ°üÁÖÀ§½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Ç÷°üÁÖÀ§½Å°æÃÑ
  • Cranial venous plexus
    ¸Ó¸®Á¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] µÎ°³Á¤¸ÆÃÑ
  • Cervical plexus
    ¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] °æ½Å°æÃÑ
  • External carotid plexus
    ¹Ù±ù¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¿Ü°æµ¿¸Æ½Å°æÃÑ
  • Vesical plexus
    ¹æ±¤½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ¹æ±¤½Å°æÃÑ
  • Vesical venous plexus
    ¹æ±¤Á¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] ¹æ±¤Á¤¸ÆÃÑ
  • Abdominal aortic plexus
    ¹è´ëµ¿¸Æ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] º¹´ëµ¿¸Æ½Å°æÃÑ
  • Celiac plexus
    º¹°­½Å°æ¾ó±â
    [¿¾ ¿ë¾î] º¹°­½Å°æÃÑ
  • Suprarenal plexus
    ºÎ½Å½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ºÎ½Å½Å°æÃÑ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ASDC Association of Sleep Disorders Centers; ¹Ì±¹ ¼ö¸é Áúȯ ¼¾ÅÍ Çùȸ
DIMS Disorders of Initiating & Maintaining Sleep; ÀÔ¸éÀå¾Ö ¹× ¼ö¸é À¯Áö Àå¾Ö; ºÒ¸éÁõ
DOES Disorders of Excessive Somnolence; °ú´Ù ¼ö¸é Àå¾Ö
SADS Schedule for Affective Disorders & Schizophrenia; ¹Ì±¹ °í¾È
AASD American Academy of Stress Disorders
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BLPD B cell lympho-proliferative disorders
CAMDEX Cambridge Mental Disorders of the Elderly Examination
CMPD Chronic myeloproliferative disorders
CDG Congenital Disorders of Glycosylation
CTD Cumulative Trauma Disorders
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • plexus of visceral vein
    ³»Àå Á¤¸Æ ¾ó±â
  • plexus pancreaticus
    ÃéÀå ½Å°æ ¾ó±â
  • plexus prostaticus
    Àü¸³»ù ½Å°æ ¾ó±â
  • plexus tympanicus
    °í½Ç ½Å°æ ¾ó±â
  • plexus venosus prostaticus
    °í¸³»ù Á¤¸Æ ¾ó±â
  • posterior cervical sympathetic plexus
    ÈİæºÎ ±³°¨½Å°æÃÑ
  • posterior, middle superior alveolar nerve plexus
    ÈÄÁß»óÄ¡Á¶ ½Å°æÃÑ
  • prevertebral sympathetic plexus
    ôÃßÀü ±³°¨ ½Å°æÃÑ
  • pterygoid plexus
    ³¯°³±Ù Á¤¸Æ ¾ó±â, À͵¹±Ù Á¤¸ÆÃÑ
  • pterygoid venous plexus
    À͵¹ Á¤¸ÆÃÑ
  • renal autonomic plexus
    ½Å ÀÚÀ² ½Å°æÃÑ
  • submucosal insert µ¿ÀǾî=mucosal insert.

    submucosal plexus

    Á¡¸· ¹Ø ½Å°æ ¾ó±â, Á¡¸·ÇÏ ½Å°æÃÑ
  • suprarenal plexus
    ºÎ½Å ½Å°æ ¾ó±â, ºÎ½Å ½Å°æÃÑ
  • sympathetic plexus
    ±³°¨ ½Å°æÃÑ
  • total plexus paralysis
    ¿ÏÀü ÃÑ ¸¶ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
personality disorders A major deviation from normal patterns of behaviour.
(12 Dec 1998)
growth disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth.
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
multifactorial or multigenic disorders Genetic disorders resulting from the combined action of alleles of more than one gene (e.g., heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single- gene disorders.
Compare single-gene disorders.
(05 Mar 2000)
consciousness disorders Organic mental disorders in which there is marked impairment of awareness.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á